We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.
Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Tome's technologies allow it to insert any genetic sequence of any size at any location in the genome with site-specific precision. The Company is writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies.
